1 | 27 2002 CANCER AND METASTASIS REVIEWS 21(3-4):349-362
Cohen V; Khuri FR
Chemoprevention of lung cancer: Current status and future prospects
LIPPMAN SM, 2001, J CLIN ONCOL S, V19, PS74 may refer to 8 LIPPMAN-SM-2001-V19-P74S2 | 29 2002 CANCER CELL 1(1):49-52
Minna JD; Roth JA; Gazdar AF
Focus on lung cancer
LIPPMAN SM, 2001, J CLIN ONCOL S, V19, PS74 may refer to 8 LIPPMAN-SM-2001-V19-P74S3 | 42 2002 CLINICAL CANCER RESEARCH 8(11):3324-3331
Rathi A; Virmani AK; Schorge JO; Elias KJ; Maruyama R; Minna JD; Mok SC; Girard L; Fishman DA; Gazdar AF
Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women
VIRMANI AK, 2001, CLIN CANCER RES, V7, P584 may refer to 7 VIRMANI-AK-2001-V7-P19984 | 82 2002 ONCOGENE 21(45):6915-6935
Zabarovsky ER; Lerman MI; Minna JD
Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers
VIRMANI AK, 2001, CLIN CANCER RES, V7, P584 may refer to 7 VIRMANI-AK-2001-V7-P19985 | 87 2002 ONCOLOGIST 7(5):451-457
Zochbauer-Muller S; Minna JD; Gazdar AF
Aberrant DNA methylation in lung cancer: Biological and clinical implications
VIRMANI AK, 2001, CLIN CANCER RES, V7, P584 may refer to 7 VIRMANI-AK-2001-V7-P1998